Total Payments
$5,495
2024 Payments
$187.85
Companies
43
Transactions
296
Medicare Patients
1,263
Medicare Billing
$120,193
Payment Breakdown by Category
Food & Beverage$5,412 (98.5%)
Education$63.70 (1.2%)
Consulting$19.76 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,412 | 290 | 98.5% |
| Education | $63.70 | 5 | 1.2% |
| Consulting Fee | $19.76 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $705.58 | 42 | $0 (2022) |
| Amgen Inc. | $545.50 | 21 | $0 (2020) |
| Merck Sharp & Dohme LLC | $518.24 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $493.26 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $421.16 | 20 | $0 (2020) |
| GlaxoSmithKline, LLC. | $343.84 | 18 | $0 (2024) |
| Lilly USA, LLC | $300.91 | 18 | $0 (2024) |
| Novo Nordisk Inc | $243.66 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $204.61 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $173.45 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187.85 | 9 | GlaxoSmithKline, LLC. ($48.69) |
| 2022 | $13.02 | 1 | PFIZER INC. ($13.02) |
| 2020 | $278.14 | 13 | Novo Nordisk Inc ($42.12) |
| 2019 | $1,362 | 73 | PFIZER INC. ($321.93) |
| 2018 | $1,749 | 89 | Amgen Inc. ($332.37) |
| 2017 | $1,905 | 111 | Astellas Pharma US Inc ($266.82) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $27.14 | General |
| 10/03/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $34.00 | General |
| 02/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: VACCINES | ||||||
| 03/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes | ||||||
| 03/12/2020 | PFIZER INC. | PREMARIN (Drug), ESTRING, COLOGUARD | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: WOMENS HEALTH | ||||||
| 03/03/2020 | Hologic, LLC | Aptima HPV (Device), Aptima Combo 2, Aptima TV | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diagnostics | ||||||
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/18/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/11/2020 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL 9 | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: WOMENS HEALTH | ||||||
| 02/07/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Obesity | ||||||
| 02/06/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Neuroscience | ||||||
| 01/31/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: RESPIRATORY | ||||||
| 01/31/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: UROLOGY | ||||||
| 01/24/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/21/2020 | Lilly USA, LLC | BAQSIMI (Drug), HUMULIN R 500 | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Diabetes | ||||||
| 12/19/2019 | PFIZER INC. | PREMARIN (Drug), ESTRING, COLOGUARD | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: WOMENS HEALTH | ||||||
| 12/05/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 290 | 371 | $90,539 | $27,573 |
| 2022 | 9 | 337 | 453 | $101,592 | $32,734 |
| 2021 | 7 | 279 | 387 | $54,481 | $28,104 |
| 2020 | 8 | 357 | 473 | $72,254 | $31,782 |
Total Patients
1,263
Total Services
1,684
Medicare Billing
$120,193
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 164 | $56,580 | $15,197 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $12,744 | $5,053 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 69 | $16,905 | $4,706 | 27.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $2,527 | $1,440 | 57.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 20 | $600.00 | $588.00 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 42 | 49 | $637.00 | $411.60 | 64.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $546.00 | $177.24 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 171 | $58,995 | $17,444 | 29.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 50 | 50 | $17,700 | $7,317 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 68 | $16,660 | $4,252 | 25.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 15 | $3,675 | $1,150 | 31.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,040 | $1,021 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $480.00 | $479.01 | 99.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 19 | 25 | $1,625 | $447.41 | 27.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $390.00 | $390.83 | 100.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 57 | 79 | $1,027 | $233.73 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 151 | $29,445 | $13,752 | 46.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 45 | 45 | $10,035 | $6,701 | 66.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 86 | $11,352 | $5,802 | 51.1% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 21 | 21 | $1,071 | $907.32 | 84.7% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 23 | 23 | $667.00 | $448.27 | 67.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 12 | 26 | $1,456 | $387.44 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 32 | 35 | $455.00 | $105.00 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 100 | 158 | $30,810 | $12,424 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 63 | 63 | $14,049 | $8,229 | 58.6% |
About Dr. Marlene Mires, MD
Dr. Marlene Mires, MD is a Family Medicine healthcare provider based in Brea, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235185976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marlene Mires, MD has received a total of $5,495 in payments from pharmaceutical and medical device companies, with $187.85 received in 2024. These payments were reported across 296 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($5,412).
As a Medicare-enrolled provider, Mires has provided services to 1,263 Medicare beneficiaries, totaling 1,684 services with total Medicare billing of $120,193. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Brea, CA
- Active Since 05/25/2006
- Last Updated 11/08/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235185976
Products in Payments
- Prolia (Biological) $460.39
- JANUVIA (Drug) $315.00
- FARXIGA (Drug) $288.11
- Myrbetriq (Drug) $266.82
- CHANTIX (Drug) $249.58
- TRADJENTA (Drug) $216.81
- TRELEGY ELLIPTA (Drug) $172.25
- JARDIANCE (Drug) $162.53
- MYRBETRIQ (Drug) $154.34
- LYRICA (Drug) $138.25
- XARELTO (Drug) $136.12
- Trintellix (Drug) $108.83
- PREMARIN (Drug) $103.88
- PREVNAR - 13 (Biological) $86.02
- Synthroid (Drug) $84.75
- RELISTOR ORAL (Drug) $83.25
- BREO (Drug) $80.68
- Ozempic (Drug) $80.42
- Vascepa (Drug) $78.07
- Androgel (Drug) $73.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brea
Dennis Shults, Do, DO
Family Medicine — Payments: $181,159
Family Medicine $181,159
Debra Gutierrez, Md, MD
Family Medicine — Payments: $17,759
Family Medicine $17,759
Dr. Kedy Jao, D.o, D.O
Family Medicine — Payments: $11,416
Family Medicine $11,416
Andrew Morrison, Md, MD
Family Medicine — Payments: $10,716
Family Medicine $10,716
John Mitchell, M.d, M.D
Family Medicine — Payments: $10,229
Family Medicine $10,229
Robert Ranney, Md, MD
Family Medicine — Payments: $10,057
Family Medicine $10,057